Niceritrol

Niceritrol (CAS No.: 5868-05-3) is a niacin-derived ester widely utilized as a biochemical reagent in lipid metabolism research, particularly in studies examining the regulation of lipoprotein dynamics and fatty acid mobilization. Functioning as a prodrug-like compound that releases nicotinic acid, Niceritrol is known to activate the G protein-coupled receptor GPR109A, thereby modulating signaling pathways associated with adipocyte lipolysis and lipid homeostasis. Experimental evidence indicates that it influences plasma lipid profiles by reducing cholesterol and triglyceride levels in very low-density and low-density lipoprotein fractions, making it a useful tool for investigating mechanisms of dyslipidemia and atherosclerosis in vitro and in animal models. Its biological activity is typically observed within low micromolar to micromolar concentration ranges, although precise experimental conditions vary depending on the model system and study design. Niceritrol is commonly applied in cellular assays and preclinical models to explore lipid metabolic pathways, adipose tissue function, and receptor-mediated signaling processes, supporting its role as a valuable compound in life science and drug discovery research contexts.